Blue Horseshoe Stocks: PCTL Still on Fire & More

PCT Ltd. PCTL – Update -

We have taken a slight detour from our typical options and big-board-heavy focus to look back to the OTC Markets, where we used to make the bulk of our bread and butter, many years ago.

The lower exchanges are still good for speculative short term trading if you know where to look, and PCTL, which we initially tagged for observation first thing  Monday morning, has now continued to move impressively through a second consecutive session. As we reported yesterday morning, on Monday the stock ran from .0089-.015 (+69%), but that was just the beginning.

We mentioned that crossing the barrier between subpenny and penny territory is a difficult thing for an OTC stock to do, and that it was an occurrence that warranted further attention in and of itself. We’re glad we didn’t let it slip off of our radars because PCTL added another huge performance yesterday. From a daily low of .0127 the stock shot to a new high of .0278! That represents an intraday gain of 119% and measured from our observed low on Monday, a total two-day increase of 212%

Tenet Healthcare Corp. THC – Fresh Options Idea -

We won’t ignore the options trading arena completely, with one idea in particular sticking out to us this morning. We are seeing some volatility arise as the stock is in a prime bottom-bounce position, and are going to want to track a couple of ideas through to the end of the week.

We are going to potentially target the THC Weekly $18-18.50 Calls, which will stand to perform well over the remaining three sessions of the week if it can begin to establish some momentum off of the bottom you can on the chart below.

Extended Watchist:

Blue Horseshoe Stocks: Fresh Bottom Plays

New Bottom Plays

While we are in a bit of a drought in terms of big name earnings reports, as tends to happen around a holiday. We’re back for a full, fresh trading week and we thought we’d shift our focus to bottom plays as we kick things off. 

Taronis Technologies, Inc. TRNX

TRNX is in precisely the sort of position in which we look for bottom-bounce candidates. The stock saw new lows last week before making its reversal, and stringing together three consecutive positive sessions.

We can also see on the RSI that TRNX is just now coming off of being extremely oversold and the volatility potential suggests that even a 100% move from current pricing would not be out of the realm of possibility. We’ll be keeping an eye peeled here in the days and weeks ahead.


Rockwell Medical Technologies, Inc. RMTI 

RMTI is another possible bottom play with some decent potential and a gap to fill the 200DMA currently sitting at 4.11. Perhaps the upside potential here is not quite of the magnitude of the previously mentioned play, but the indicators may be more ripe in this case.

The MACD is on the precipice of a bullish cross, and the RSI is slowly attempting to come off of being oversold. This may also be a good candidate for a more sustained recovery over the next several sessions.

Extended Watchlist:

Blue Horseshoe Stocks: Cannabis Reminder

Cannabis Reminder

With the cannabis counterculture holiday of 04/20 capping off this week on Friday, you can bet that our tracking of the cannabis sector is going to ramp up right along with many of these stocks.

It was back on the 4th of this month that we published an extensive list of marijuana industry stocks to track in anticipation of this event. For those outside the loop, “Four-Twenty” is a massive celebration each year on April 20th, to commemorate the cultural tradition of partaking in cannabis at 4:20pm on any given day. Cannabis companies use this as the perfect marketing ploy, and as a result, many do their highest sales of the year on the heels of this holiday.

A few of the plays we highlighted earlier this month have already begun to see appreciable moves on the chart. Take OWC Pharma (OWCP) for example. Since the 4th, the stock has increased from .20 to .30, a 50% rise in under two weeks.

We would expect to see similar, and even better gains coming from many cannabis stocks all across the board. That’s why we wanted to open up this week with a reminder to keep a close eye on anything even remotely tied to the space.

Just refresh, some of those stocks include, but are not limited to:


Extended Watchlist:

Blue Horseshoe Stocks: EQLB, TPIV, CHKE & More

EQ Labs, Inc. EQLB

EQLB was the big standout from yesterday’s report, performing extremely well after receiving first-billing in our premarket extended watchist. We caught this momentum play on an early scan and were very pleased to have included a mention of the stock as it blasted off right out of the starting gate.

From an initial low of .0035, EQLB surged as high as .0062 for a very respectable 77% intraday rip on excessive volume; it traded its one month average ten times over. It and our next mention accounted for two of the top three most-actively traded stocks on the OTC, so we were certainly poking our noses in the right place.

With momentum carrying over from the previous session to yesterday, moving forward, we’ll be open two the possibilities of either a sustained uptrend, or a potential dip-and-rip scenario.

TapImmune, Inc. TPIV

Our other nice spot from yesterday’s report was TPIV, which caught our eye in the wake of an early PR relating to one of its vaccine’s inclusion in a USDOD-funded study.

We had already been following the stock all summer; regular readers will recall our tracking this play to double-bag gains back in June. That history, the press, and a ripening chart more-than warranted another mention, and it turned out well. TPIV ran from an early low of .52, and steadily rose toward its HOD of .68, marking a 31% increase.

We’ll certainly continue to monitor its progress, especially given the fact that it maintained nearly all of its daily advances, closing just a penny off of the high at .67.

Cherokee, Inc. CHKE

Our readers are well aware of our penchant for bargain hunting, and we’ve got a potential bottom-watch candidate in CHKE to bring to the table today. The stock recently underwent a huge gap-down as a result of poorly-received earnings, and on Monday, was been beaten back to its annual lows.

That sort of activity always draws our attention, and in this case, the snap-back could be quite significant with a huge gap to fill on the chart. Add in analyst price targets ranging from $21-33, and this play begins to look out of place at such a low PPS. We’ll be scanning this one continuously for signs of recovery.

Extended Watchlist: